Skip to main content
. 2015 Oct 7;17(3):510–519. doi: 10.22074/cellj.2015.11

Table 1.

Distribution of CYP1A1*2C polymorphism genotypes in CML patients and controls


Genotype Patients (n=132) n (%) Controls (n=140) n (%) OR 95% CI P value

Ile/Ile (AA)- Wild 50 (38) 22 (16) 3.2705 1.84 - 5.81 0.0001
Ile/Val (AG)- Hetero 76 (57) 110 (78) 0.3701 0.218-0.63 0.0002
Val/Val (GG)- Homo mutant 6 (5) 8 (6) 0.7857 0.265-2.33 0.6635

CML; Chronic myeloid leukemia, n; Number of subjects, OR; Odds ratio and CI; Confidence interval.